» Articles » PMID: 32180853

Computerised Tomography Scan in Multi-drug-resistant Versus Extensively Drug-resistant Tuberculosis

Overview
Journal Pol J Radiol
Publisher Termedia
Specialty Radiology
Date 2020 Mar 18
PMID 32180853
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Multi-drug-resistant tuberculosis (MDR-TB) is simultaneously resistant to isoniazid and rifampin. Of course, this germ may also be resistant to other anti-tuberculosis drugs. Patients with extensively drug-resistant tuberculosis (XDR-TB) are also resistant to all types of fluoroquinolone and at least one of the three injectable medications: amikacin, clarithromycin, or kanamycin, in addition to isoniazid and rifampin. Therefore, the main objective of the current study was to evaluate and compare the computed tomography (CT) scan findings of MDR-TB and XDR-TB patients.

Material And Methods: In this comparative descriptive cross-sectional study 45 consecutive TB patients who referred to Masih Daneshvari Hospital, Tehran, Iran from 2013 to 2019 were enrolled. TB was diagnosed based on sputum smear and sensitive molecular and microbial tests. Patients were divided into two groups (MDR-TB and XDR-TB) based on two types of drug resistance. CT scan findings were compared for cavitary, parenchymal, and non-parenchymal disorders. The early diagnostic values of these factors were also calculated.

Results: Findings related to cavitary lesions including the pattern, number, size of the largest cavity, maximum thickness of the cavity, lung involvement, number of lobes involved, and the air-fluid levels in the two patient groups were similar ( > 0.05). Parenchymal findings of the lung also included fewer and more nodules of 10 mm in the MDR-TB and XDR-TB groups, respectively. Tree-in-bud, ground-glass-opacity, bronchiectasis, cicatricial emphysema, and lobar atelectasis were similar in the two patient groups ( > 0.05). Findings outside the parenchymal lung, including mediastinal lymphadenopathy and pericardial effusion, showed no statistically significant difference between the MDR-TB and XDR-TB groups ( > 0.05). Parenchymal calcification was more common in the XDR group than in the MDR group (64.7% and 28.6%, respectively) with a significant difference ( = 0.01).

Conclusions: CT scan findings in patients with XDR-TB are similar to those of patients with MDR-TB for cavitary, parenchymal, and non-parenchymal lung characteristics. However, patients with XDR-TB tend to have more parenchymal calcification and left-sided plural effusion. CT characteristics overlap between XDR-TB and those with MDR-TB. It can be concluded that CT scan features are not sensitive to the diagnosis.

Citing Articles

Chinese expert consensus on imaging diagnosis of drug-resistant pulmonary tuberculosis.

Xu C, Lu P, Li C, He Y, Fang W, Xie R Quant Imaging Med Surg. 2024; 14(1):1039-1060.

PMID: 38223121 PMC: 10784038. DOI: 10.21037/qims-23-1223.


Differences in pulmonary nodular consolidation and pulmonary cavity among drug-sensitive, rifampicin-resistant and multi-drug resistant tuberculosis patients: the Guangzhou computerized tomography study.

Fang W, Tang S, Liang R, Zheng Q, Yao D, Hu J Quant Imaging Med Surg. 2024; 14(1):1010-1021.

PMID: 38223080 PMC: 10783999. DOI: 10.21037/qims-23-694.


Clinical and Computed Tomography Features Associated with Multidrug-Resistant Pulmonary Tuberculosis: A Retrospective Study in China.

Li C, Fan X, Lv S, Liu X, Wang J, Li Y Infect Drug Resist. 2023; 16:651-659.

PMID: 36743337 PMC: 9897068. DOI: 10.2147/IDR.S394071.


Differences in pulmonary nodular consolidation and pulmonary cavity among drug-sensitive, rifampicin-resistant and multi-drug resistant tuberculosis patients: a computerized tomography study with history length matched cases.

Song Q, Zheng C, Wang K, Huang X, Tartakovsky M, Wang Y J Thorac Dis. 2022; 14(7):2522-2531.

PMID: 35928612 PMC: 9344412. DOI: 10.21037/jtd-22-145.


Evaluating the relationship between high-resolution computed tomography findings and their extent in eosinophilic lung diseases with peripheral blood eosinophil level.

Mehrian P, Kiani A, Bandegani N, Razavi F, Moazzezi S, Rostami Y Pol J Radiol. 2021; 86:e542-e547.

PMID: 34820030 PMC: 8607830. DOI: 10.5114/pjr.2021.110643.


References
1.
Cha J, Lee H, Lee K, Koh W, Kwon O, Yi C . Radiological findings of extensively drug-resistant pulmonary tuberculosis in non-AIDS adults: comparisons with findings of multidrug-resistant and drug-sensitive tuberculosis. Korean J Radiol. 2009; 10(3):207-16. PMC: 2672175. DOI: 10.3348/kjr.2009.10.3.207. View

2.
Fishman J, Sais G, Schwartz D, Otten J . Radiographic findings and patterns in multidrug-resistant tuberculosis. J Thorac Imaging. 1998; 13(1):65-71. DOI: 10.1097/00005382-199801000-00015. View

3.
Lee E, Park C, Goo J, Yim J, Kim H, Lee H . Computed tomography features of extensively drug-resistant pulmonary tuberculosis in non-HIV-infected patients. J Comput Assist Tomogr. 2010; 34(4):559-63. DOI: 10.1097/RCT.0b013e3181d472bc. View

4.
Kim H, Hwang S, Kim H, Lee S, Yoo C, Kim Y . Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis. Clin Infect Dis. 2007; 45(10):1290-5. DOI: 10.1086/522537. View

5.
Geng E, Kreiswirth B, Burzynski J, Schluger N . Clinical and radiographic correlates of primary and reactivation tuberculosis: a molecular epidemiology study. JAMA. 2005; 293(22):2740-5. DOI: 10.1001/jama.293.22.2740. View